Clinical trials
Not yet recruiting Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
815 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 9 |
| 2023 | 35 |
| 2024 | 106 |
| 2025 | 206 |
| 2026 | 447 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 815 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 64 |
| Sun Yat-sen University | 56 |
| Tianjin Medical University Cancer Institute and Hospital | 34 |
| Ruijin Hospital | 22 |
| The First Affiliated Hospital with Nanjing Medical University | 17 |
| Peking University Cancer Hospital & Institute | 15 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 14 |
| Peking Union Medical College Hospital | 13 |
| Peking University People's Hospital | 13 |
| Shanghai Zhongshan Hospital | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 52 |
| Breast Neoplasms | 34 |
| Colorectal Neoplasms | 27 |
| Squamous Cell Carcinoma of Head and Neck | 24 |
| Stomach Neoplasms | 22 |
| Carcinoma, Hepatocellular | 21 |
| Rectal Neoplasms | 18 |
| Pancreatic Neoplasms | 17 |
| Esophageal Squamous Cell Carcinoma | 16 |
| Lung Neoplasms | 15 |
Trials
Showing 1 to 25 of 815. Each trial links to its page on Pharma Observatory.
715 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.